Key takeaways
Foundayo (oforglipron) and Wegovy (semaglutide) are both once-daily oral GLP-1 pills for weight loss. Oral Wegovy is also FDA-approved for cardiovascular risk reduction.
The biggest difference between Foundayo and Wegova is convenient dosing: Foundayo can be taken at any time, with or without food. Wegovy must be taken on an empty stomach, with limited water, and followed by 30 minutes of no eating or drinking.
Both oral drugs are effective for weight management. People in Wegovy clinical trials lost more weight than those in Foundayo clinical trials. Of course, individual weight loss may vary.
Not long ago, oral Wegovy (semaglutide) was the only needle-free GLP-1 receptor agonist medication for chronic weight management. In April 2026, a GLP-1 tablet called Foundayo (orforglipron) hit the market. Now that there are two GLP-1 pills for weight loss, patients have a real choice and a few key differences to weigh before talking to a healthcare provider.
Key differences
The biggest difference between Foundayo and oral Wegovy is dosing convenience. Foundayo is effective even when taken at any time of day, with or without food, while the Wegovy pill requires a strict morning fasting protocol. Other differences include the manufacturer, the active ingredient, and average weight-loss results in clinical trials.
That said, Foundayo and Wegovy share more similarities than differences. Both are oral GLP-1 medications taken once daily, and both are approved for weight management in adults with obesity or who are overweight and have at least one weight-related health condition.
Compare Foundayo vs. Wegovy key differences |
||
|---|---|---|
| Feature | Foundayo | Wegovy (semaglutide tablet) |
| Drug class | Non-peptide small-molecule GLP-1 receptor agonist | GLP-1 receptor agonist (peptide-based) |
| Manufacturer | Eli Lilly | Novo Nordisk |
| FDA approval (pill form) | April 2026 | December 2025 |
| Dosage form | Oral tablet (once daily) | Oral tablet (once daily) |
| Dosing restrictions | No time-of-day, food, or water restrictions; no waiting period before eating or taking other medications | Must be taken first thing in the morning on an empty stomach with no more than 4 oz (120 mL) of water; 30 minutes before eating, drinking anything else, or taking other medications |
| Average weight loss (highest dose, clinical trials) | ~12.4% of body weight | ~13.6% of body weight |
Conditions treated
Both Foundayo and oral Wegovy are approved by the Food and Drug Administration (FDA) for chronic weight management in adults. Oral Wegovy is also FDA-approved to reduce the risk of major cardiovascular complications (heart attack, stroke, or death) in adults with established heart disease who also have obesity or are overweight.
The injectable form of Wegovy is also approved to treat certain types of fatty liver disease, but the oral Wegovy pill is not. Neither Foundayo nor Wegovy is approved to treat Type 2 diabetes. Only semaglutide, sold under the brand name Ozempic, is approved for diabetes management.
Compare Foundayo vs. Wegovy conditions treated |
||
|---|---|---|
| Indication | Foundayo | Wegovy (oral tablet) |
| Chronic weight management (obesity, BMI 30+) | FDA approved | FDA approved |
| Chronic weight management (overweight, BMI 27+ with a weight-related condition) | FDA approved | FDA approved |
| Cardiovascular risk reduction | Not approved | FDA approved |
| Type 2 diabetes | Not approved | Not approved (Ozempic is approved for diabetes) |
How to take Foundayo
Foundayo is a once-daily tablet taken by mouth and swallowed whole — never crushed or chewed. Unlike semaglutide-based pills such as Wegovy, Foundayo has no timing or food restrictions. It can be taken at any time of day, with or without food, and with any amount of water.
“Foundayo having some flexibility is huge,” says Supriya Rao, MD, a board-certified gastroenterologist, obesity medicine, and lifestyle medicine physician in the greater Boston area. “Being able to take it without food and at any time of the day makes it easier to maintain. But, the best medication for the patient is the one they can realistically stick to.”
According to the prescribing information, Foundayo dosage starts at 0.8 milligrams (mg) once daily. The dose can be increased every 30 days until a maintenance dose of 5.5 mg, 9 mg, 14.5 mg, or 17.2 mg is reached. The maximum Foundayo dosage is 17.2 mg per day.
How to take Wegovy
The Wegovy pill is also taken once daily, but it has strict timing and fasting requirements. “Oral Wegovy won’t work as well if a patient eats or drinks too soon after,” Dr. Rao says.
Wegovy must be taken first thing in the morning, on an empty stomach, with no more than 4 ounces (120 milliliters) of water. Patients must then wait 30 minutes before eating, drinking, or taking any other medication or supplement. This fasting window matters because oral semaglutide’s absorption is significantly reduced when taken with food or larger amounts of liquid. Dr. Rao says patients who travel frequently or take multiple medications might find these restrictions challenging.
According to the prescribing information, oral Wegovy dosage starts at 1.5 mg once daily. The dose can be increased every 30 days, escalating from 4 mg to 9 mg to 25 mg, until a maintenance dose is reached. The maximum Wegovy pill dose is 25 mg per day.
Is Wegovy better than Foundayo for weight loss?
In separate clinical trials, the Wegovy pill led to slightly greater weight loss than Foundayo. At the highest approved doses, oral Wegovy reduced body weight by approximately 13.6%, while Foundayo reduced body weight by approximately 12.4%.
It’s important to understand that these comparisons are indirect. There have been no head-to-head trials comparing Foundayo and Wegovy. That said, Novo Nordisk, the manufacturer of Wegovy, published an indirect comparison of weight-loss results from oforglipron versus oral semaglutide at the highest doses. The analysis suggested that Wegovy can drive approximately 3% more weight loss than Foundayo.
Research is ongoing, and individual results may vary. “Sustainable, long-term progress is more important than chasing the highest percentage of weight loss,” Dr. Rao says. “It’s a case-by-case scenario.”
Foundayo vs. Wegovy: Insurance coverage and cost comparison
The out-of-pocket cost of Foundayo and Wegovy varies depending on dose, pharmacy price, and insurance coverage. Weight loss medications are not always covered by insurance; commercial plans are not required to cover medications that treat obesity, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Medicare does not cover weight loss medication, and Medicaid coverage varies by state.
Without insurance or discounts, the average retail cost of Foundayo is approximately $845 for 30 tablets of (the starting dose) 0.8 mg, and the average retail cost of Wegovy is approximately $1,805 for 30 tablets of (the starting dose) 1.5 mg. A SingleCare discount card can lower the price of Foundayo to approximately $601 for 30 tablets of 0.8 mg, or the price of Wegovy to approximately $1,011 for 30 tablets of 1.5 mg. Enter your ZIP code on either drug page to compare prices at pharmacies near you.
Compare Foundayo vs. Wegovy cost & coverage |
||
|---|---|---|
| Coverage details | Foundayo | Wegovy |
| Typically covered by insurance? | Unlikely; (varies by plan) | Unlikely; (varies by plan) |
| Typically covered by Medicare Part D? | No | No |
| Typically covered by Medicaid? | Unlikely; (varies by state) | Unlikely; (varies by state) |
| SingleCare cost | $601 per 30, 0.8 mg tablets at Kroger | $1,011 per 30, 1.5 mg tablets at Kroger |
| How to save with SingleCare | Get coupon | Get coupon |
Foundayo vs. Wegovy side effects
Foundayo and Wegovy share similar side effects, most of which tend to go away as the body adjusts to the medication. Both medications are started at a small dosage and slowly titrated upward to help decrease adverse side effects.
According to the drug labels, the most common side effects of both medications are:
- Nausea
- Vomiting
- Constipation
- Diarrhea
- Headache
- Fatigue
Hypoglycemia, or low blood sugar, is a serious side effect of Foundayo and Wegovy. Other rare but serious side effects include pancreatitis, kidney problems, and gallbladder disease.
Consult a healthcare professional for a complete list of side effects, and don’t hesitate to call your prescriber about severe or worsening symptoms taking Foundayo or Wegovy.
Foundayo and Wegovy drug interactions and warnings
Foundayo and Wegovy have slightly different drug interactions. With Wegovy, the best way to avoid interactions is to follow the dosing instructions: take it on an empty stomach and wait 30 minutes before eating, drinking, or taking other medications.
CYP3A4 inhibitors (like clarithromycin, diltiazem, and verapamil) and inducers (like rifampin, carbamazepine, and phenytoin) affect Foundayo’s own levels, not the levels of other medications. The dose adjustments are for Foundayo itself, not to the CYP3A4 inhibitors or inducers. If you take Foundayo, the maximum dose of the cholesterol-lowering drug simvastatin should be 20 mg.
The drug labels for Foundayo and Wegovy warn against taking them if you have a personal or family history of medullary thyroid cancer or MEN2 syndrome. These medications should not be taken during pregnancy or breastfeeding.
Which medication is right for you?
The decision between Foundayo and oral Wegovy should be made jointly by the patient and the healthcare provider. Several factors go into this decision, including the patient’s nutrition and exercise habits, schedule, budget, and other medications.
“I may choose Foundayo over Wegovy if patients desire an oral option but are opposed to the early morning dosing and delayed oral intake, if they desire flexibility due to an irregular schedule, and if their weight loss goals are less urgent,” says Chrissie Ott, MD, a board-certified internist, pediatrician, and obesity medicine physician in Portland, Oregon.
Dr. Rao says patients should think beyond pure efficacy numbers. “I don’t want patients to look at which medication causes the most weight loss the quickest and pick that one,” she says. “Patients need to think about which one would realistically fit their lifestyle and their health goals.”
Cost is another factor. Dr. Ott says either Foundayo or Wegovy can be a great choice for weight loss, but she would consider which is a better fit for her patient’s budget or insurance coverage. “I would also note that there are more steps to target dose on Foundayo, so that may be relevant in that it may take longer to see maximal effects,” she adds.
Ultimately, only a healthcare professional with a complete picture of your health, goals, and lifestyle can help decide whether Foundayo, Wegovy, or another weight-loss medication is right for you.
Expert takeaway
Leslie Greenberg, MD, Associate Professor of Family and Community Medicine at the University of Nevada, Reno Family Medicine Residency Program and member of the SingleCare Medical Review Board, notes that “medical weight loss is an extremely personal decision. Everyone is on a different journey with a different path.”
Optimizing nutrition, physical activity, sleep, and other healthy behaviors prior to initiating pharmacologic weight-loss therapy may improve weight-loss outcomes, help preserve lean body mass, and increase function and stamina.
Frequently asked questions
Is Foundayo better than Wegovy for weight loss?
In separate clinical trials, the Wegovy pill led to slightly greater weight loss than Foundayo. But that doesn’t necessarily mean Wegovy is better, as there haven’t been any head-to-head clinical trials.
What’s the difference between Foundayo and the Wegovy pill?
The key difference is convenience. Foundayo can be taken at any time of day, with or without food, and with any amount of water. The Wegovy pill has a strict protocol: take it first thing in the morning on an empty stomach with no more than 4 ounces of water, then wait 30 minutes before eating, drinking, or taking other medications.
How much do Foundayo and Wegovy cost, and are they covered by insurance?
Without insurance or discounts, Foundayo costs approximately $845 per month, and Wegovy retails at approximately $1,805 per month. Prices vary based on dose strength, pharmacy, and location. Coverage also varies. Commercial insurance plans are not required to cover weight-loss medications, Medicare does not cover them, and Medicaid coverage varies by state.
The SingleCare prices in this article are the most accurate at the time of publishing in ZIP code 23666 as of Jul. 6, 2026. Prices vary by pharmacy. Visit our coupon page for updated drug prices at pharmacies near you.
- Foundayo (orforglipron) tablets, for oral use, U.S. Food and Drug Administration (2026)
- Wegovy (semaglutide) injection, for subcutaneous use, U.S. Food and Drug Administration (2026)
- Effect of various dosing schedules on the pharmacokinetics of oral semaglutide: A randomised trial in healthy subjects, Clinical Pharmacokinetics (2023)
- Prescription medications to treat overweight and obesity, National Institute of Diabetes and Digestive and Kidney Diseases (2024)
- Wegovy pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a population-adjusted indirect comparison, Novo Nordisk (2026)
- Research study looking at how well semaglutide tablets taken once daily work in people who have a body weight above the healthy range (OASIS 4), Clinical Trials (2026)
- A study of orforglipron (LY3502970) in adult participants with obesity or overweight with weight-related comorbidities (ATTAIN-1), Clinical Trials (2026)
- Oral semaglutide at a dose of 25 mg in adults with overweight or obesity, The New England Journal of Medicine (2025)
- Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment, The New England Journal of Medicine (2025)
- Oral semaglutide vs orforglipron for obesity – an indirect comparison, Novo Nordisk (2026)
- Medically accurate: SingleCare’s Medical Review Board analyzes all of our content to confirm it’s in line with current medical advice.
- Evidence-based: Our content is sourced from reputable U.S.-based healthcare professionals and peer-reviewed research.
- Trustworthy: All of SingleCare’s content goes through a multi-phase review process by our writers, editors, and Medical Board in order to provide clear and credible information.